Results 201 to 210 of about 10,572,234 (361)

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Author Response to Letter on “Blood Pressure and Hypertension in Adolescents and Young Adults: Results From a Nationwide Screening Program”

open access: yesThe Journal of Clinical Hypertension
Wesley Teck Wee Loo   +9 more
doaj   +1 more source

Social context shapes facial dynamics: human and machine decoding of conversation topics. [PDF]

open access: yesSci Rep
Putra P   +5 more
europepmc   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

open access: yesMolecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller   +17 more
wiley   +1 more source

Time Series Classification using Deep Learning for Process Planning: A Case from the Process Industry

open access: diamond, 2017
Nijat Mehdiyev   +5 more
openalex   +1 more source

Textural Features for Image Classification

open access: yesIEEE Transactions on Systems, Man and Cybernetics, 1973
R. Haralick, K. Shanmugam, I. Dinstein
semanticscholar   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Segmentation and classification of road markings using MLS data

open access: green, 2016
Mario Soilán   +3 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy